ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AMRN Amarin Corp PLC

0.8393
0.00 (0.00%)
Pre Market
Last Updated: 12:10:02
Delayed by 15 minutes
Name Symbol Market Type
Amarin Corp PLC NASDAQ:AMRN NASDAQ Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 0.8393 0.842 0.855 1 12:10:02

AMARIN CORPORATION INVESTOR ALERT: Gibbs Law Group Files Class Action Lawsuit Alleging Violations of Federal Securities Laws

22/02/2019 11:18pm

Business Wire


Amarin (NASDAQ:AMRN)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Amarin Charts.

Gibbs Law Group announces that it has filed a class action lawsuit against Amarin Corporation (NASDAQ: AMRN) and certain of its officers and directors. The class action, filed in the United States District Court for the District of New Jersey (No. 2:19-cv-6601), is on behalf of investors who purchased or acquired the securities of Amarin Corporation (NASDAQ: AMRN) from September 24, 2018 through November 8, 2018, inclusive. The lawsuit seeks to recover damages for Amarin investors under the Securities Exchange Act of 1934.

To speak privately with an attorney regarding this class action lawsuit, click here.

According to the lawsuit, defendants made false and misleading statements or failed to disclose that: (1) the top-line results Amarin touted about its REDUCE-IT trial for Vascepa were not as positive as the company represented; (2) the placebo given to patients in the control arm of REDUCE-IT may have increased the incidence of cardiovascular events in those patients; (3) as a result, Amarin’s public statements were materially false and misleading at all relevant times.

A class action lawsuit has already been filed. If you suffered a loss in Amarin, you have until April 23, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

To speak privately with a securities attorney to learn more about our investigation and your legal rights, visit our website or contact our securities team directly at (800) 808-5294.

About Gibbs Law Group

Gibbs Law Group represents individual and institutional investors in securities litigation to correct abusive corporate governance practices, breaches of fiduciary duty, and proxy violations. The firm has recovered over a billion dollars for its clients against some of the world’s largest corporations, and our attorneys have received numerous honors for their work, including “Best Lawyers in America,” “Top Plaintiff Lawyers in California,” “Top Class Action Attorneys Under 40,” “Consumer Protection MVP,” and “Top Cybersecurity/ Privacy Attorneys Under 40.”

This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

CONTACT: EILEEN EPSTEINPHONE: 510.350.9728EMAIL: EJE@CLASSLAWGROUP.COM

1 Year Amarin Chart

1 Year Amarin Chart

1 Month Amarin Chart

1 Month Amarin Chart

Your Recent History

Delayed Upgrade Clock